CV Sciences (CVSI) Short term Debt (2013 - 2026)

CV Sciences (CVSI) reported Short term Debt of $72000.0 for Q1 2026, down 90.65% on a YoY basis from $770000.0 in Q1 2025, and down 94.29% sequentially from $1.3 million in Q4 2025.

CV Sciences (CVSI) Short term Debt (2013 - 2026) Analysis & Trends

CV Sciences (CVSI) has 8 years of Short term Debt data on file, last reported at $72000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Short term Debt fell 90.65% year-over-year to $72000.0; the trailing twelve-month figure through Mar 2026 stood at $72000.0 (down 90.65% YoY), and the FY2025 full-year result was $1.3 million, up 86.41% from the prior year.
  • Short term Debt eased to $72000.0 in Q1 2026, from $1.3 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.3 million in Q4 2025 to a low of $72000.0 in Q1 2026.
  • A 3-year average of $709166.7 and a median of $723500.0 in 2024 frame the typical range for Short term Debt.
  • Across the five-year window, Short term Debt surged 86.41% in 2025 and slumped 90.65% in 2026, its largest moves.
  • Tracing CVSI's Short term Debt over 3 years: stood at $677000.0 in 2024, then surged by 86.41% to $1.3 million in 2025, then plunged by 94.29% to $72000.0 in 2026.
  • Business Quant data shows CVSI's Short term Debt at $72000.0 in Q1 2026, $1.3 million in Q4 2025, and $451000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 72,000.00
Dec 31, 2025 1.26 Mn
Sep 30, 2025 451,000.00
Jun 30, 2025 1.02 Mn
Mar 31, 2025 770,000.00
Dec 31, 2024 677,000.00
Mar 31, 2018 323,086.00
Dec 31, 2017 609,926.00
Sep 30, 2017 1.14 Mn
Jun 30, 2017 1.35 Mn
Mar 31, 2017 718,595.00
Dec 31, 2016 125,964.00
Sep 30, 2016 1.97 Mn
Jun 30, 2016 1.71 Mn
Mar 31, 2016 250,000.00
Dec 31, 2015 250,000.00
Sep 30, 2013 30,000.00